Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer.

Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer.
复制标题

早期生长反应1在miR-20b转录调节乳腺癌中的关键作用。

DOI:
10.18632/oncotarget.1165
复制
发表时间:
2013-09
期刊:
影响因子:
--
通讯作者:
Kovalchuk O
Kovalchuk O
中科院分区:
其他
文献类型:
--
作者:
Li D;Ilnytskyy Y;Kovalchuk A;Khachigian LM;Bronson RT;Wang B;Kovalchuk O

文献摘要

参考文献

被引文献

相似文献

控制乳腺癌发病机制的miRNAs的转录调控在很大程度上仍然未知。在这里,我们发现,电离辐射,一种已知的乳腺癌致癌物质,触发了乳腺组织中miR-20 b的差异表达。我们在miR-20 b启动子中鉴定了锌指转录因子早期生长反应-1(EGR 1)的几个富含GC的共有结合基序。miR-20 b在乳腺癌细胞系HCC 1806中被IR上调,并且其上调与EGR 1表达相关。因此,我们以HCC 1806细胞为模型系统,探讨EGFR 1在miR-20 b转录中的作用。siRNA敲除EGR 1减弱miR-20 b表达。荧光素酶测定显示,EGR 1刺激由野生型miR-20 b启动子驱动的荧光素酶活性,而这种诱导在突变型miR-20启动子构建体中被消除。我们注意到,与正常人乳腺上皮细胞相比,HCC 1806细胞中miR-20 b启动子处的EGFR 1显著富集。抑制miR-20 b可显著抑制HCC 1806细胞的增殖和迁移,并导致细胞阻滞于G 0/G1期和S期。体外RNA下拉分析表明,miR-20 b靶向许多肿瘤抑制因子,包括在HCC 1806中下调的PTEN和BRCA 1。相反,miR-20 b的抑制增加了PTEN和BRCA 1水平。此外,免疫组化和FISH分析显示,乳腺癌组织中miR-20 b的表达与EGFR 1水平显著相关。因此,我们的研究结果首次证明,EGFR 1是miR-20 b转录控制的关键参与者,而miR-20 b可能反过来作为癌基因通过肿瘤抑制因子靶向促进乳腺肿瘤发生。
Transcriptional regulation of miRNAs that control the pathogenesis of breast cancer remains largely unknown. Here, we showed that ionizing radiation, a known breast carcinogen, triggered the differential expression of miR-20b in mammary tissues. We identified several GC-rich consensus binding motifs for the zinc finger transcription factor early growth response-1 (EGR1) in miR-20b promoter. miR-20b was upregulated by IR and its upregulation correlated with EGR1 expression in the breast cancer cell line HCC1806. Therefore, we used HCC1806 cells as a model system to explore the role of EGR1 in miR-20b transcription. siRNA knockdown of EGR1 attenuated miR-20b expression. Luciferase assays showed that whereas EGR1 stimulated luciferase activity driven by the wild-type miR-20b promoter, this induction was abolished in the mutant miR-20 promoter construct. We noted significant enrichment of EGR1 at miR-20b promoter in HCC1806 cells compared with normal human mammary epithelial cells. Suppression of miR-20b significantly inhibited HCC1806 cell proliferation and migration, and led to G 0/G 1 and S phase arrest. In vitro RNA-pull down assays indicated that miR-20b targets numerous tumor suppressors, including PTEN and BRCA1, which were downregulated in HCC1806. Conversely, suppression of miR-20b increased PTEN and BRCA1 levels. Moreover, immunohistochemical and FISH analyses showed that the miR-20b expression correlated significantly with EGR1 levels in breast cancer tissues. Our findings thus demonstrate for the first time that EGR1 is a key player in the transcriptional control of miR-20b, and miR-20b may in turn function as an oncogene by contributing to breast tumorigenesis via tumor suppressor targeting.
DOI: 10.1038/nprot.2010.62
发表时间: 2010-01-01
期刊: NATURE PROTOCOLS
影响因子: 14.8
作者:
de Planell-Saguer, Mariangels;Celina Rodicio, Maria;Mourelatos, Zissimos
通讯作者: Mourelatos, Zissimos
DOI: 10.1073/pnas.0906947106
发表时间: 2009-09-15
影响因子: 11.1
作者:
Castellano, Leandro;Giamas, Georgios;Stebbing, Justin
通讯作者: Stebbing, Justin
DOI: 10.1161/01.cir.0000140764.15398.f3
发表时间: 2004-09-01
期刊: CIRCULATION
影响因子: 37.8
作者:
Chen, WJ;Lin, KH;Pang, JHS
通讯作者: Pang, JHS
DOI: 10.1182/blood-2008-07-163907
发表时间: 2009-01-08
期刊: BLOOD
影响因子: 20.3
作者:
Inomata, Mika;Tagawa, Hiroyuki;Sawada, Kenichi
通讯作者: Sawada, Kenichi
DOI: 10.4161/cc.7.11.5981
发表时间: 2008-06-01
期刊: CELL CYCLE
影响因子: 4.3
作者:
Koturbash, Igor;Zemp, Franz J.;Kovalchuk, Olga
通讯作者: Kovalchuk, Olga